ישראל - עברית - Ministry of Health

cts ltd - rotigotine 4 mg / 24 hour - patches - rotigotine - neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through the late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or "on-off" fluctuations).

ישראל - עברית - Ministry of Health

cts ltd - rotigotine 6 mg / 24 hour - patches - rotigotine - neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through the late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or "on-off" fluctuations).

ישראל - עברית - Ministry of Health

cts ltd - rotigotine 8 mg / 24 hour - patches - rotigotine - neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through the late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or "on-off" fluctuations).